Robert Califf
Search results
Janet Woodcock (born August 29, 1948) is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA).
Feb 1, 2024 · Janet Woodcock is the FDA’s Principal Deputy Commissioner. In this role she works closely with the Commissioner of Food and Drugs to develop and implement key public health initiatives...
- Principal Deputy Commissioner
- Office of The Commissioner
Nov 16, 2023 · U.S. Food and Drug Administration (FDA) Principal Deputy Commissioner Dr. Janet Woodcock, who led the regulator during the height of the COVID-19 pandemic as acting chief, plans to retire early...
Nov 16, 2023 · US Food and Drug Administration Deputy Commissioner Janet Woodcock will retire next year after nearly four decades at the regulator that were marked by controversy over support for unproven medications for rare, serious conditions. Woodcock confirmed the news in an email.
Nov 17, 2023 · WOODCOCK SET TO RETIRE — Longtime FDA regulator Janet Woodcock, who has worked at the agency since 1986, plans to retire in early 2024, FDA Commissioner Robert Califf told agency staff Thursday.
Nov 16, 2023 · Woodcock, a 37-year veteran of the FDA, was acting commissioner at the beginning of the Biden administration and a key decision-maker on controversial drugs and COVID-19 response. She will leave the agency after facing criticism for approving opioids, Alzheimer’s and muscular dystrophy drugs.
This Wednesday will be Dr. Janet Woodcock@s last day at the US Food and Drug Administration (FDA), capping a remarkable 38-year career at the agency. She@s been called one of the most powerful and influential drug regulators worldwide.
